BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-ABy Nasdaq OMXMay 24, 2017, 1:26 PM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-ABy Nasdaq OMXMay 24, 2017, 1:26 PM UTC